伐昔洛韦新的儿科剂型：研发与生物等效性评估。 - Suppr | 超能文献

A new paediatric formulation of valaciclovir: development and bioequivalence assessment.

作者信息

Bastiaans Diane E T, Bartels-Wilmer Carli M, Colbers Angela P H, Heijens Claudia A W, Velthoven-Graafland Kirsten, Smeets Oscar S N M, Vink Nicole, Harbers Veroniek E M, Warris Adilia, Burger David M

机构信息

Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.

Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Arch Dis Child. 2016 Oct;101(10):971-2. doi: 10.1136/archdischild-2015-310266. Epub 2016 May 9.

DOI:10.1136/archdischild-2015-310266

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A new paediatric formulation of valaciclovir: development and bioequivalence assessment.伐昔洛韦新的儿科剂型：研发与生物等效性评估。

Arch Dis Child. 2016 Oct;101(10):971-2. doi: 10.1136/archdischild-2015-310266. Epub 2016 May 9.

2

In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir.伐昔洛韦一种新的儿科制剂的体内和体外适口性测试。

Br J Clin Pharmacol. 2017 Dec;83(12):2789-2797. doi: 10.1111/bcp.13396. Epub 2017 Sep 20.

3

Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness.伐昔洛韦在患有爱泼斯坦-巴尔病毒疾病儿童中的药代动力学及安全性

Drugs R D. 2002;3(6):365-73. doi: 10.2165/00126839-200203060-00001.

4

Bioequivalence studies of two different film-coated tablet formulations of valacyclovir of two different strengths in healthy volunteers.两种不同规格的伐昔洛韦薄膜包衣片在健康志愿者中的生物等效性研究。

Arzneimittelforschung. 2010;60(5):273-81. doi: 10.1055/s-0031-1296285.

5

Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.盐酸伐昔洛韦胶囊在中国健康男性志愿者单剂量给药后的药代动力学和生物等效性研究。

Arzneimittelforschung. 2010;60(3):162-7. doi: 10.1055/s-0031-1296266.

6

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers.阿昔洛韦前体药物伐昔洛韦在对正常志愿者进行单剂量和多剂量递增给药后的药代动力学。

Clin Pharmacol Ther. 1993 Dec;54(6):595-605. doi: 10.1038/clpt.1993.196.

7

Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy.多剂量伐昔洛韦在接受和未接受利尿剂治疗的老年志愿者中的药代动力学及安全性

Antimicrob Agents Chemother. 1996 Jan;40(1):80-5. doi: 10.1128/AAC.40.1.80.

8

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans.阿昔洛韦的L-缬氨酸酯伐昔洛韦口服给药后在人体内的绝对生物利用度和代谢情况。

Antimicrob Agents Chemother. 1995 Dec;39(12):2759-64. doi: 10.1128/AAC.39.12.2759.

9

Pharmacokinetics of acyclovir in the cat.阿昔洛韦在猫体内的药代动力学。

J Vet Pharmacol Ther. 1996 Dec;19(6):488-90. doi: 10.1111/j.1365-2885.1996.tb00087.x.

10

[Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster].[阿昔洛韦和伐昔洛韦的中枢神经系统不良反应风险。单纯疱疹和带状疱疹治疗中需关注肾功能]

Lakartidningen. 2007;104(24-25):1916-20.

引用本文的文献

1

Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update.儿童用复方非无菌制剂和美国食品药品监督管理局批准的市售液体产品：北美最新情况

Pharmaceutics. 2022 May 10;14(5):1032. doi: 10.3390/pharmaceutics14051032.

2

In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir.伐昔洛韦一种新的儿科制剂的体内和体外适口性测试。

Br J Clin Pharmacol. 2017 Dec;83(12):2789-2797. doi: 10.1111/bcp.13396. Epub 2017 Sep 20.